The World Health Organization (WHO) has recommended the use of the first-ever malaria vaccine for children. WHO Director-General Tedros Adhanom Ghebreyesus endorsed the RTS,S/AS01 malaria or Mosquirix - a vaccine developed by British drugmaker GlaxoSmithKline (GSK).


  1. Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended broad use of a vaccine against a human parasite.
  2. The vaccine acts against plasmodium falciparum -- one of five parasite species and the most deadly.
  3. The symptoms of malaria are--fever, headaches, and muscle pain, then cycles of chills, fever, and sweating.
  4. The Vaccine was recommending children in sub-Saharan Africa and in other regions with moderate to high malaria transmission get four doses up to the age of two.
  5. Malaria claims the lives of more than 400,000 people every year. Children account for 67% of all malaria deaths worldwide, according to the WHO.

Countries that have eliminated malaria

  1. Globally, the elimination net is widening, with more countries moving towards the goal of zero malaria. In 2019, 27 countries reported fewer than 100 indigenous cases of the disease, up from 6 countries in 2000.
  2. Countries that have achieved at least 3 consecutive years of zero indigenous cases of malaria are eligible to apply for the WHO certification of malaria elimination.
  3. Over the last two decades, 11 countries have been certified by the WHO Director-General as malaria-free: United Arab Emirates (2007), Morocco (2010), Turkmenistan (2010), Armenia (2011), Sri Lanka (2016), Kyrgyzstan (2016), Paraguay (2018), Uzbekistan (2018), Algeria (2019), Argentina (2019), and El Salvador (2021).